ADALIMUMAB News
ADALIMUMAB currently has 0 news articles, with 21 predicted indications.
This page combines the AI-predicted indications for ADALIMUMAB with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (21):
- ankylosing spondylitis (99.0%)
- juvenile idiopathic arthritis (99.0%)
- juvenile arthritis due to defect in LACC1 (99.0%)
- non-infectious uveitis (99.0%)
- psoriatic arthritis (99.0%)
- dyshidrosis (99.0%)
- spondyloarthropathy, susceptibility to (99.0%)
- Crohn disease (99.0%)
- inflammatory bowel disease (99.0%)
- hidradenitis (99.0%)
- rheumatoid arthritis (99.0%)
- hidradenitis suppurativa (99.0%)
- Crohn's colitis (99.0%)
- spondyloarthropathy (99.0%)
- ulcerative colitis (disease) (99.0%)
- rheumatoid vasculitis (99.8%)
- hypermobility of coccyx (99.8%)
- inflammatory spondylopathy (99.8%)
- Kummell disease (99.7%)
- polyarticular juvenile rheumatoid arthritis (99.7%)
- vertebral disease (99.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.